BPH Energy Ltd
ASX:BPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rossari Biotech Ltd
NSE:ROSSARI
|
IN |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.6), the stock would be worth AU$0.02 (109% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.3 | AU$0.01 |
0%
|
| 3-Year Average | 0.6 | AU$0.02 |
+109%
|
| 5-Year Average | 1.5 | AU$0.04 |
+415%
|
| Country Average | 2.7 | AU$0.08 |
+838%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
B
|
BPH Energy Ltd
ASX:BPH
|
10.8m AUD | 0.3 | -9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 142.4 | 4 280.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
176.7B USD | 3.3 | 26.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
125.4B USD | 2.4 | 34 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 6.8 | 46.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
298.9B CNY | 3.8 | 15.6 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.3B CHF | 3.8 | -118.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.7B USD | 4.7 | 25.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.4B USD | 11.9 | 47.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.5B USD | 4.3 | 20.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.1B USD | -1 104.7 | 30 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
BPH Energy Ltd
Glance View
BPH Energy Ltd. engages in the development of biomedical research and technologies within universities and hospital institutes. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-08-06. The Company’s principal activities include Cortical Dynamics, Advent Energy Limited, Molecular Discovery Systems (MD Systems) and the HLS5 Project. Cortical Dynamics is working with BPH Energy and Swinburne University of Technology to develop and commercialize anaesthesia monitoring systems for use during surgery. Advent Energy Limited holds a portfolio of exploration assets throughout Australia and has its project in petroleum exploration permit 11. MD Systems is a class of anti-mitotic drugs, which has undergone preclinical testing of anti-cancer activity. MD Systems is working with the Western Australian Institute for Medical Research to develop and validate HLS5 as a tumor suppressor gene.
